Amneal Pharmaceuticals Email Format

Pharmaceutical ManufacturingNew Jersey, United States5001-10000 Employees

Amneal Pharmaceuticals, Inc. is a pharmaceutical manufacturer located at 400 Crossing Boulevard in Bridgewater, New Jersey, with an estimated 5,001 to 10,000 employees. The company maintains a diversified portfolio that includes complex generics and injectables, biosimilars, and specialty medicines, totaling more than 290 products. Amneal is publicly traded on the NASDAQ under the ticker AMRX. In 2026, Amneal completed the acquisition of Kashiv BioSciences LLC for about $1.1 billion, expanding its asset base. Also in 2026, the company announced U.S. FDA approval of romidepsin injection solution and disclosed plans to renovate and expand facilities in North Bellport, New York, and Attleboro, Massachusetts, including approximate staff additions through 2028.

Get verified Amneal Pharmaceuticals emails free

Company overview Employee directory